Manufacturer of Controlled Substances; Notice of Application, 30418-30419 [E8-11633]
Download as PDF
<![CDATA[
30418
Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Dated: May 20, 2008.
Gary D. Cooper,
District Manager.
[FR Doc. E8–11722 Filed 5–23–08; 8:45 am]
BILLING CODE 4310–GG–P
DEPARTMENT OF THE INTERIOR
Minerals Management Service
Extension of Post-Sale Evaluation
Period for Central Gulf of Mexico
Lease Sale 206
Minerals Management Service
(MMS), Interior.
ACTION: Notice to Extend Post-Sale
Evaluation Period for Central Gulf of
Mexico Lease Sale 206.
AGENCY:
SUMMARY: This notice extends by 30
days, the post-sale evaluation period for
Central Gulf of Mexico Lease Sale 206.
The Minerals Management Service
(MMS) will complete evaluating all the
bids received in this sale by July 17,
2008. This action is necessary due to the
unusually high number of bids received
in this lease sale.
DATES: The post-sale evaluation period
ends on June 17, 2008.
FOR FURTHER INFORMATION CONTACT:
David Marin, Regional Supervisor,
Resource Evaluation, Gulf of Mexico
Region, telephone 504–736–2710.
SUPPLEMENTARY INFORMATION: In the
Central Gulf of Mexico Sale 206, held
March 19, 2008, we received 1057 bids
on 615 tracts, 513 tracts of which passed
to a second phase requiring additional
detailed evaluations. The aggressive
bidding activity is due, in part, to the
high number of quality prospects on
recently expired unexplored tracts in
newly established deepwater
hydrocarbon plays and to the cost
saving technological advances related to
hydrocarbon exploration and
development in the Gulf of Mexico’s
deepwater environment. The unusually
high number of bids received on a large
number of tracts, and the high volume
of exclusively reprocessed data
identified on Sale 206, significantly
increases the workload for reviewing the
adequacy of bids. Consequently, MMS is
unable to conduct and complete the bid
review process within the 90 days, i.e.,
by June 17, 2008. Under the provisions
of § 256.47(e)(2), MMS is extending the
bid evaluation period until July 17,
2008.
Dated: May 5, 2008.
Lars Herbst,
Regional Director, Gulf of Mexico OCS Region.
[FR Doc. E8–11711 Filed 5–23–08; 8:45 am]
substance intermediates for sale to its
customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 28, 2008.
BILLING CODE 4310–MR–P
Dated: May 15, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–11631 Filed 5–23–08; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on April 25, 2008,
Siegfried (USA), Inc., Industrial Park
Road, Pennsville, New Jersey 08070,
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Oripavine(9330), a basic class of
controlled substance listed in schedule
II.
The company will use the above
listed controlled substance in the
manufacture of other controlled
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 21,
2007, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New
York 12144, made application by
renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
pwalker on PROD1PC71 with NOTICES
Marihuana (7360) ......................................................................................................................................................
Tetrahydrocannabinols (7370) ...................................................................................................................................
Amphetamine (1100) .................................................................................................................................................
Lisdexamfetamine (1205) ..........................................................................................................................................
Methylphenidate (1724) .............................................................................................................................................
Pentobarbital (2270) ..................................................................................................................................................
Hydrocodone (9193) ..................................................................................................................................................
Meperidine (9230) ......................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage form) (9273) ..............................................................................................
Oxymorphone (9652) .................................................................................................................................................
Fentanyl (9801) ..........................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development and for
VerDate Aug<31>2005
17:22 May 23, 2008
Jkt 214001
distribution to its customers. In
reference to drug code 7360
(Marihuana), the company plans to bulk
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
II
II
II
II
II
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
E:\FR\FM\27MYN1.SGM
27MYN1
Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than July 28, 2008.
Dated: May 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–11633 Filed 5–23–08; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL ARCHIVES AND RECORDS
ADMINISTRATION
Records Schedules; Availability and
Request for Comments
National Archives and Records
Administration (NARA).
ACTION: Notice of availability of
proposed records schedules; request for
comments.
pwalker on PROD1PC71 with NOTICES
AGENCY:
SUMMARY: The National Archives and
Records Administration (NARA)
publishes notice at least once monthly
of certain Federal agency requests for
records disposition authority (records
schedules). Once approved by NARA,
records schedules provide mandatory
instructions on what happens to records
when no longer needed for current
Government business. They authorize
the preservation of records of
continuing value in the National
Archives of the United States and the
destruction, after a specified period, of
records lacking administrative, legal,
research, or other value. Notice is
published for records schedules in
which agencies propose to destroy
records not previously authorized for
disposal or reduce the retention period
of records already authorized for
disposal. NARA invites public
comments on such records schedules, as
required by 44 U.S.C. 3303a(a).
VerDate Aug<31>2005
17:22 May 23, 2008
Jkt 214001
Requests for copies must be
received in writing on or before June 26,
2008. Once the appraisal of the records
is completed, NARA will send a copy of
the schedule. NARA staff usually
prepare appraisal memorandums that
contain additional information
concerning the records covered by a
proposed schedule. These, too, may be
requested and will be provided once the
appraisal is completed. Requesters will
be given 30 days to submit comments.
ADDRESSES: You may request a copy of
any records schedule identified in this
notice by contacting the Life Cycle
Management Division (NWML) using
one of the following means:
Mail: NARA (NWML), 8601 Adelphi
Road, College Park, MD 20740–6001
E-mail: requestschedule@nara.gov.
FAX: 301–837–3698.
Requesters must cite the control
number, which appears in parentheses
after the name of the agency which
submitted the schedule, and must
provide a mailing address. Those who
desire appraisal reports should so
indicate in their request.
FOR FURTHER INFORMATION CONTACT:
Laurence Brewer, Director, Life Cycle
Management Division (NWML),
National Archives and Records
Administration, 8601 Adelphi Road,
College Park, MD 20740–6001.
Telephone: 301–837–1539. E-mail:
records.mgt@nara.gov.
SUPPLEMENTARY INFORMATION: Each year
Federal agencies create billions of
records on paper, film, magnetic tape,
and other media. To control this
accumulation, agency records managers
prepare schedules proposing retention
periods for records and submit these
schedules for NARA’s approval, using
the Standard Form (SF) 115, Request for
Records Disposition Authority. These
schedules provide for the timely transfer
into the National Archives of
historically valuable records and
authorize the disposal of all other
records after the agency no longer needs
them to conduct its business. Some
schedules are comprehensive and cover
all the records of an agency or one of its
major subdivisions. Most schedules,
however, cover records of only one
office or program or a few series of
records. Many of these update
previously approved schedules, and
some include records proposed as
permanent.
The schedules listed in this notice are
media neutral unless specified
otherwise. An item in a schedule is
media neutral when the disposition
instructions may be applied to records
regardless of the medium in which the
records are created and maintained.
DATES:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
30419
Items included in schedules submitted
to NARA on or after December 17, 2007,
are media neutral unless the item is
limited to a specific medium. (See 36
CFR 1228.24(b)(3).)
No Federal records are authorized for
destruction without the approval of the
Archivist of the United States. This
approval is granted only after a
thorough consideration of their
administrative use by the agency of
origin, the rights of the Government and
of private persons directly affected by
the Government’s activities, and
whether or not they have historical or
other value.
Besides identifying the Federal
agencies and any subdivisions
requesting disposition authority, this
public notice lists the organizational
unit(s) accumulating the records or
indicates agency-wide applicability in
the case of schedules that cover records
that may be accumulated throughout an
agency. This notice provides the control
number assigned to each schedule, the
total number of schedule items, and the
number of temporary items (the records
proposed for destruction). It also
includes a brief description of the
temporary records. The records
schedule itself contains a full
description of the records at the file unit
level as well as their disposition. If
NARA staff has prepared an appraisal
memorandum for the schedule, it too
includes information about the records.
Further information about the
disposition process is available on
request.
Schedules Pending
1. Department of Agriculture, Food
Safety and Inspection Service (N1–462–
07–1, 1 item, 1 temporary item). Master
file associated with an electronic
information system used to analyze food
inspection performance data. The
proposed disposition instructions are
limited to electronic records.
2. Department of Homeland Security,
Office of Public Affairs (N1–563–07–17,
13 items, 8 temporary items). Nonexecutive level biographies; routine
photographs; agreements for nongovernmental, entertainment-oriented
projects requesting use of the agency
seal, insignia, and other assistance; and
working papers and background
materials. Proposed for permanent
retention are executive level
biographies, communication plans,
mission-related photographs, press
conference records, and press releases.
3. Department of Homeland Security,
United States Citizenship and
Immigration Services (N1–566–08–12, 2
items, 2 temporary items). Inputs and
master file associated with a local area
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 73, Number 102 (Tuesday, May 27, 2008)]
[Notices]
[Pages 30418-30419]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11633]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on September 21, 2007, AMRI
Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made
application by renewal to the Drug Enforcement Administration (DEA) as
a bulk manufacturer of the basic classes of controlled substances
listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360).......................... I
Tetrahydrocannabinols (7370).............. I
Amphetamine (1100)........................ II
Lisdexamfetamine (1205)................... II
Methylphenidate (1724).................... II
Pentobarbital (2270)...................... II
Hydrocodone (9193)........................ II
Meperidine (9230)......................... II
Dextropropoxyphene, bulk (non-dosage form) II
(9273)...................................
Oxymorphone (9652)........................ II
Fentanyl (9801)........................... II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers. In
reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled
substance will be further synthesized to bulk
[[Page 30419]]
manufacture a synthetic THC (7370). No other activity for this drug
code is authorized for this registration.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 28, 2008.
Dated: May 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-11633 Filed 5-23-08; 8:45 am]
BILLING CODE 4410-09-P
